1. References 1. Ayobami O, Willrich N, Suwono B, Eckmanns T, Markwart R. The epidemiology of carbapenem-non-susceptible Acinetobacter species in Europe: analysis of EARS-Net data from 2013 to 2017. Antimicrob Resist Infect Control [Internet]. 2020;9(1):89. Available from: https://doi.org/10.1186/s13756-020-00750-5 2. Atrouni A Al, Joly-Guillou ML, Hamze M, Kempf M. Reservoirs of non-baumannii Acinetobacter species. Front Microbiol. 2016;7(FEB):1-12. 3. Shamsizadeh Z, Nikaeen M, Esfahani BN, Mirhoseini SH, Hatamzadeh M, Hassanzadeh A. Detection of antibiotic resistant Acinetobacter baumannii in various hospital environments: potential sources for transmission of Acinetobacter infections. Environ Health Prev Med. 2017;22(1):1-7. 4. Forster DH, Daschner FD. Acinetobacter species as nosocomial pathogens. Eur J Clin Microbiol Infect Dis. 1998;17(2):73-7. 5. Abdulzahra AT, Khalil MAF, Elkhatib WF. First report of colistin resistance among carbapenem-resistant Acinetobacter baumannii isolates recovered from hospitalized patients in Egypt. New microbes new Infect. 2018;26:53-8. 6. McDonald LC, Banerjee SN, Jarvis WR, System NNIS. Seasonal variation of Acinetobacter infections: 1987-1996. Clin Infect Dis. 1999;29(5):1133-7. 7. Spellberg B, Bonomo RA. "Airborne assault": a new dimension in Acinetobacter baumannii transmission. Crit Care Med. 2013;41(8). 8. Doughari HJ, Ndakidemi PA, Human IS, Benade S. The ecology, biology and pathogenesis of Acinetobacter spp.: an overview. Microbes Environ. 2009;1103150282. 9. Rossau R, Van Landschoot A, Gillis M, De Ley J. Taxonomy of Moraxellaceae fam. nov., a new bacterial family to accommodate the genera Moraxella, Acinetobacter, and Psychrobacter and related organisms. Int J Syst Evol Microbiol. 1991;41(2):310-9. 10. Dijkshoorn L, van der Toorn J. Acinetobacter species: which do we mean? Clin Infect Dis. 1992;15(4):748-9. 11. Visca P, Seifert H, Towner KJ. Acinetobacter infection - An emerging threat to human health. IUBMB Life. 2011;63(12):1048-54. 12. Munier A-L, Biard L, Legrand M, Rousseau C, Lafaurie M, Donay J-L, et al. Incidence, risk factors and outcome of multi-drug resistant Acinetobacter baumannii nosocomial infections during an outbreak in a burn unit. Int J Infect Dis. 2019;79:179-84. 13. Oberoi A, Aggarwal A, Lal M. A Decade of an Underestimated Nosocomal Pathogen-Acinetobacter In a Tertiary Care Hospital in Punjab. JK Sci. 2009;11(1). 14. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5(12):939-51. 15. Grupper M, Sprecher H, Mashiach T, Finkelstein R. Attributable mortality of nosocomial Acinetobacter bacteremia. Infect Control Hosp Epidemiol. 2007;28(3):293-8. 16. Klein SL, Jedlicka A, Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis. 2010;10(5):338-49. 17. Dunn SE, Ousman SS, Sobel RA, Zuniga L, Baranzini SE, Youssef S, et al. Correction: Peroxisome proliferator-activated receptor (PPAR) α expression in T cells mediates gender differences in development of T cell-mediated autoimmunity. J Exp Med. 2018;215(6):1765. 18. Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626-38. 19. Voskuhl R. Sex differences in autoimmune diseases. Biol Sex Differ. 2011;2(1):1-21. 20. Scotland RS, Stables MJ, Madalli S, Watson P, Gilroy DW. Sex differences in resident immune cell phenotype underlie more efficient acute inflammatory responses in female mice. Blood, J Am Soc Hematol. 2011;118(22):5918-27. 21. Abid S, Xie S, Bose M, Shaul PW, Terada LS, Brody SL, et al. 17β-estradiol dysregulates innate immune responses to Pseudomonas aeruginosa respiratory infection and is modulated by estrogen receptor antagonism. Infect Immun. 2017;85(10):e00422-17. 22. Vermillion MS, Ursin RL, Attreed SE, Klein SL. Estriol reduces pulmonary immune cell recruitment and inflammation to protect female mice from severe influenza. Endocrinology. 2018;159(9):3306-20. 23. Lone R, Shah A, Kadri SM, Lone S, Faisal S. Nosocomial multi-drug-resistant Acinetobacter infections-clinical findings, risk factors and demographic characteristics. Bangladesh J Med Microbiol. 2009;3(1):34-8. 24. Gupta N, Gandham N, Jadhav S, Mishra RN. Isolation and identification of Acinetobacter species with special reference to antibiotic resistance. J Nat Sci Biol Med. 2015;6(1):159-62. 25. Bhattacharyya S, Bhattacharyya I, Rit K, Mukhopadhyay PK, Dey JB, Ganguly U, et al. Antibiogram of Acinetobacter spp. isolated from various clinical specimens in a tertiary care hospital in West Bengal, India. Biomed Res. 2013;24(1). 26. Jain AL, Harding CM, Assani K, Shrestha CL, Haga M, Leber A, et al. Characteristics of invasive Acinetobacter species isolates recovered in a pediatric academic center. BMC Infect Dis. 2016;16(1):1-9. 27. Poirel L, Bonnin RA, Nordmann P. Genetic basis of antibiotic resistance in pathogenic Acinetobacter species. IUBMB Life. 2011;63(12):1061-7. 28. Sadiq Z, Sehlawi A. Isolation and Identification of Acinetobacter baumannii Clinical Isolates using Novel Methods. J Babylon Univ. 2014;22(3). 29. AL-Baroody HN, Al-Ghanimi AAK. Isolation and Identification of Nosocomial Pathogen Acinetobacter baumannii From Al-Hussien Medical City in Karbala. Sci J Med Res. 2020;4(14):54-9. 30. Lahiri KK, Mani NS, Purai SS. Acinetobacter spp as nosocomial pathogen: Clinical significance and antimicrobial sensitivity. Med J Armed Forces India. 2004;60(1):7-10. 31. Hejnar P, Kolář M, Hájek V. Characteristics of Acinetobacter strains (phenotype classification, antibiotic susceptibility and production of ss-lactamases) isolated from haemocultures from patients at the Teaching Hospital in Olomouc. Biomed Pap. 1999
2. 32. Yadav SK, Bhujel R, Hamal P, Mishra SK, Sharma S, Sherchand JB. Burden of multidrug-resistant Acinetobacter baumannii infection in hospitalized patients in a tertiary care hospital of Nepal. Infect Drug Resist. 2020;13:725-32. 33. Patel RV, Shah JS, Revathi G, Siika W, Shah R. Acinetobacter infections: a retrospective study to determine inhospital mortality rate and clinical factors associated with mortality. Infect Prev Pract [Internet]. 2019;1(2):100010. Available from: https://doi.org/10.1016/j.infpip.2019.100010 34. Humphreys H, Fitzpatick F, Harvey BJ. Gender differences in rates of carriage and bloodstream infection caused by methicillin-resistant Staphylococcus aureus: are they real, do they matter and why? Clin Infect Dis. 2015;61(11):1708-14. 35. Vincent J-L, Sakr Y, Singer M, Martin-Loeches I, Machado FR, Marshall JC, et al. Prevalence and outcomes of infection among patients in intensive care units in 2017. Jama. 2020;323(15):1478-87. 36. Neubeiser A, Bonsignore M, Tafelski S, Alefelder C, Schwegmann K, Rüden H, et al. Mortality attributable to hospital acquired infections with multidrug-resistant bacteria in a large group of German hospitals. J Infect Public Health. 2020;13(2):204-10. 37. Eliopoulos GM, Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis. 2008;46(8):1254-63. 38. Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR. Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review. Front Microbiol. 2019;10:539. 39. Blanco N, Harris AD, Rock C, Johnson JK, Pineles L, Bonomo RA, et al. Risk factors and outcomes associated with multidrug-resistant Acinetobacter baumannii upon intensive care unit admission. Antimicrob Agents Chemother. 2018;62(1):e01631-17. 40. Kong BH, Hanifah YA, Yusof MYM, Thong KL. Antimicrobial susceptibility profiling and genomic diversity of multidrug-resistant Acinetobacter baumannii isolates from a teaching hospital in Malaysia. Jpn J Infect Dis. 2011;64(4):337-40. 41. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007;51(10):3471-84. 42. Manchanda V, Sanchaita S, Singh NP. Multidrug resistant acinetobacter. J Glob Infect Dis. 2010;2(3):291. 43. Ahmed MU, Farooq R, Al Hawashim N, Ahmed M, Yiannakou N, Sayeed F, et al. Sensitive, resistant and multi-drug resistant Acinetobacter baumanii at Saudi Arabia hospital eastern region. Pak J Pharm Sci. 2015;28(3).
3. The epidemiology of carbapenem-non-susceptible Acinetobacter species in Europe: analysis of EARS-Net data from 2013 to 2017
4. Reservoirs of Non-baumannii Acinetobacter Species
5. Detection of antibiotic resistant Acinetobacter baumannii in various hospital environments: potential sources for transmission of Acinetobacter infections